Skip To Main Content
Barbara Loesch on Muck Rack

Barbara Loesch

As seen in: The BMJ, Trading View
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

21 The IFN-γ Biosensor - a universal tool for IFN-γ detection in cellular co-culture assays

|
By Barbara Loesch, Kanuj Mishra, Justyna Ogonek, Dolores Schendel
| The BMJ Verified
Regular and Young Investigator Award Abstracts Biomarkers, Immune Monitoring and Novel Technologies 21 The IFN-γ Biosensor – a universal tool for IFN-γ detection in cellular co-culture assays Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Open in Who Shared View Duplicates (154) Issue with article?

Medigene to Present at Upcoming Scientific Conferences

|
By Medigene PR, Justyna Ogonek, Dolores Schendel, Barbara Loesch
| Trading View
Business news for the stock market Medigene AG: Medigene to Present at Upcoming Scientific Conferences Planegg/Martinsried (pta000/16.10.2024/11:30 UTC+2) Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, will present at the 16th Annual Protein & Antibody Engineering Summit (PEGS) to be held from November 5-7, 2024 in Barcelona as well...
Open in Who Shared View Duplicates (138) Issue with article?
See all 3 articles